These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 35384369)

  • 21. Levosimendan restores both systolic and diastolic cardiac performance in lipopolysaccharide-treated rabbits: comparison with dobutamine and milrinone.
    Barraud D; Faivre V; Damy T; Welschbillig S; Gayat E; Heymes C; Payen D; Shah AM; Mebazaa A
    Crit Care Med; 2007 May; 35(5):1376-82. PubMed ID: 17414729
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rehospitalization of Patients with Advanced Heart Failure Receiving Continuous, Palliative Dobutamine or Milrinone.
    Eaton RE; Kissling KT; Haas GJ; McLaughlin EM; Pickworth KK
    Am J Cardiol; 2022 Dec; 184():80-89. PubMed ID: 36167736
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methodological Perspectives from 'Milrinone for the Treatment of Acute Heart Failure After Acute Myocardial Infarction: A Systematic Review and Meta-analysis'.
    Novaes RD; Gonçalves RV
    Basic Clin Pharmacol Toxicol; 2015 Dec; 117(6):368. PubMed ID: 26359127
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparison of dobutamine-based and milrinone-based therapy for advanced decompensated congestive heart failure: Hemodynamic efficacy, clinical outcome, and economic impact.
    Yamani MH; Haji SA; Starling RC; Kelly L; Albert N; Knack DL; Young JB
    Am Heart J; 2001 Dec; 142(6):998-1002. PubMed ID: 11717603
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Do positive inotropic agents adversely affect the survival of patients with chronic congestive heart failure? III. Antagonist's viewpoint.
    Colucci WS
    J Am Coll Cardiol; 1988 Aug; 12(2):566-9. PubMed ID: 2899101
    [No Abstract]   [Full Text] [Related]  

  • 26. Milrinone as Compared with Dobutamine in the Treatment of Cardiogenic Shock.
    Gibson LE; Chang MG; Berra L
    N Engl J Med; 2021 Nov; 385(22):2108. PubMed ID: 34818494
    [No Abstract]   [Full Text] [Related]  

  • 27. Milrinone as Compared with Dobutamine in the Treatment of Cardiogenic Shock.
    Potter BJ
    N Engl J Med; 2021 Nov; 385(22):2107-2108. PubMed ID: 34818493
    [No Abstract]   [Full Text] [Related]  

  • 28. Milrinone as Compared with Dobutamine in the Treatment of Cardiogenic Shock. Reply.
    Mathew R; Di Santo P; Hibbert B
    N Engl J Med; 2021 Nov; 385(22):2108-2109. PubMed ID: 34818495
    [No Abstract]   [Full Text] [Related]  

  • 29. Treatment of ischaemic left ventricular dysfunction with milrinone or dobutamine administered during coronary artery stenosis in the presence of beta blockade in pigs.
    Sidi A; Muehlschlegel JD; Kirby DS; Lobato EB
    Br J Anaesth; 2006 Dec; 97(6):799-807. PubMed ID: 17035336
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inotropic therapy for right ventricular failure in newborn piglets: effect on contractility, hemodynamics, and interventricular interaction.
    Hyldebrandt JA; Frederiksen CA; Heiberg J; Rothmann S; Redington AN; Schmidt MR; Ravn HB
    Pediatr Crit Care Med; 2014 Sep; 15(7):e327-33. PubMed ID: 25080150
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased cost effectiveness with nesiritide vs. milrinone or dobutamine in the treatment of acute decompensated heart failure.
    Scroggins N; Edwards M; Delgado R
    Congest Heart Fail; 2005; 11(6):311-4. PubMed ID: 16330906
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Physiological bases and therapeutic uses of inodilator drugs].
    Costa R; De Marino V; Marino A
    Clin Ter; 1991 Jan; 136(2):85-94. PubMed ID: 1827377
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Parenteral inotropic support for advanced congestive heart failure.
    Leier CV; Binkley PF
    Prog Cardiovasc Dis; 1998; 41(3):207-24. PubMed ID: 9872607
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Levosimendan treatment of severe acute congestive heart failure refractory to dobutamine/milrinone in children].
    Prijić S; Rakić S; Nikolić L; Jovicić B; Stajević M; Vukomanović V; Kosutić J
    Vojnosanit Pregl; 2011 Nov; 68(11):979-84. PubMed ID: 22191317
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Response to milrinone treatment in patients with chronic congestive heart failure].
    Zeng H; Wen S; Huang D; Liu X; Fang Y
    Hua Xi Yi Ke Da Xue Xue Bao; 2000 Jun; 31(2):246-7, 259. PubMed ID: 12515150
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of milrinone and dobutamine in low cardiac output states: Systematic review and meta-analysis.
    Mathew R; Visintini SM; Ramirez FD; DiSanto P; Simard T; Labinaz M; Hibbert BM
    Clin Invest Med; 2019 Jun; 42(2):E26-32. PubMed ID: 31228965
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dobutamine-related asthma in a patient awaiting cardiac transplantation: the eosinophilic dilemma.
    Aranda JM; Woo G; Pauly DF; Rodriguez E; Hill JA; Schofield RS
    J Heart Lung Transplant; 2004 Feb; 23(2):260-1. PubMed ID: 14761776
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Congestive heart failure.
    Ruggie N
    Med Clin North Am; 1986 Jul; 70(4):829-51. PubMed ID: 3012226
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is monitoring milrinone therapy useful in advanced heart failure?
    Vazir A; Leaver N; Lyster H; Alexanian A; Wilton P; Banner NR
    Int J Cardiol; 2011 Jun; 149(3):380-1. PubMed ID: 21450357
    [No Abstract]   [Full Text] [Related]  

  • 40. Acute decompensated heart failure: the shrinking role of inotropic therapy.
    Dec GW
    J Am Coll Cardiol; 2005 Jul; 46(1):65-7. PubMed ID: 15992637
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.